Arcadia Biosciences, Inc. (RKDA) Balance Sheet

NASDAQ: RKDAAssets, liabilities, debt and equity over 10 years.

RKDA balance sheet, 2025

December 31, 2025 · U.S. dollars

$6.5M assets = $2.4M liabilities + $4.1M equity

What it owns$6.5MCash & ST investments: $4.6M (69.7%)Cash & ST investments$4.6M · 70%Receivables: $425,000 (6.5%)Receivables $425,000Inventory: $1.2M (18.5%)Inventory$1.2M · 19%Other current: $156,000 (2.4%)PP&E: $8,000 (0.1%)Goodwill & intangibles: $39,000 (0.6%)Other non-current: $143,000 (2.2%)=How it is financed$6.5MCurrent liabilities: $2.1M (31.5%)Current liabilities$2.1M · 31%Other LT liabilities: $347,000 (5.3%)Shareholders’ equity: $4.1M (63.2%)Shareholders’ equity$4.1M · 63%

Both columns are drawn to the same scale: what RKDA owns equals what it owes plus shareholders’ equity. Hover a block for its value.

RKDA financial health

Current ratio3.09
Comfortable · current assets cover current liabilities 3.09×
Equity / assets63.2%
Equity-funded · of assets funded by shareholders
Goodwill & intangibles0.6%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

RKDA balance sheet trends, 2016–2025

Arcadia Biosciences, Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$56.6M2016$6.5M2025−21.3%/yr
Total liabilities$34.4M2016$2.4M2025−25.6%/yr
Shareholders’ equity$22.2M2016$4.1M2025−17.0%/yr
Cash & short-term investments$50.6M2016$4.6M2025−23.5%/yr
Total debt$25.1M2016$155,0002024−47.1%/yr
Net cash (debt)$25.4M2016$4.1M2024−$21.3M
Working capital$49.1M2016$4.3M2025−$44.8M
Book value per share$58.442021$3.032025−52.3%/yr
Current ratio16.6920163.092025−13.60
Debt / equity1.1320160.022024−1.11
Shares outstanding532K20211.4M2025+26.6%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

RKDA assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

RKDA liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

RKDA debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

RKDA balance sheet

Arcadia Biosciences, Inc. annual balance sheet
2025202420232022202120202019201820172016
Assets
Cash & short-term investments$4.6M$4.2M$11.6M$20.6M$28.7M$25.7M$25.3M$21.8M$13.0M$50.6M
Cash & equivalents$259,000$4.2M$6.5M$20.6M$28.7M$14.0M$8.4M$12.0M$9.1M$2.0M
Short-term investments$4.3M$0$5.1M$0$0$11.6M$16.9M$9.8M$3.9M$48.5M
Receivables$425,000$1.2M$514,000$1.2M$1.4M$1.4M$602,000$168,000$1.2M$533,000
Inventory$1.2M$904,000$2.0M$2.3M$4.4M$3.8M$1.8M$181,000$229,000$252,000
Other current assets$156,000$2.9M$858,000$1.2M$900,000$811,000$712,000$704,000$560,000$877,000
Total current assets$6.4M$9.2M$15.0M$25.4M$35.4M$31.7M$28.4M$22.9M$15.0M$52.2M
Property, plant & equipment (net)$8,000$178,000$1.2M$2.5M$5.4M$9.4M$3.8M$395,000$299,000$508,000
Goodwill & intangible assets$39,000$39,000$39,000$40,000$484,000$778,000$0$0$0$0
Long-term investments$0$0$0$0$0$0$0$0$0$2.5M
Other non-current assets$143,000$4.1M$3.5M$956,000$2.7M$5.5M$372,000$753,000$1.2M$1.3M
Total assets$6.5M$13.5M$19.7M$28.9M$43.9M$47.3M$32.6M$24.0M$16.6M$56.6M
Liabilities
Accounts payable$1.5M$703,000$801,000$905,000$1.4M$726,000$492,000$285,000$366,000$222,000
Short-term debt—$155,000$852,000$1.0M$1.1M$1.9M$635,000$29,000—$25.1M
Deferred revenue——−$572,000—$64,000$8,000$42,000$96,000$1.0M$740,000
Total current liabilities$2.1M$2.6M$3.6M$4.2M$5.0M$6.3M$5.7M$3.1M$3.5M$3.1M
Long-term debt$0$0$0$0$0$2.1M$107,000$0$0$25.1M
Lease obligations$0$155,000$1.0M$2.0M$3.3M$6.1M$2.1M———
Other long-term liabilities$347,000$4.7M$3.4M$3.8M$7.7M$10.4M$18.4M$8.2M$5.0M$6.1M
Total liabilities$2.4M$7.3M$7.0M$8.0M$12.7M$18.8M$24.2M$11.2M$8.6M$34.4M
Shareholders' equity
Common stock & paid-in capital$65,000$65,000$65,000$65,000$63,000$54,000$49,000$45,000$42,000$44,000
Retained earnings (deficit)−$281.2M−$278.9M−$271.8M−$257.9M−$226.5M−$211.8M−$207.2M−$178.4M−$167.3M−$151.6M
Treasury stock————————$0$0
Accumulated other comprehensive income——$101,000—$0$0$1,000−$4.8M−$1,000−$19,000
Minority interest—$0−$138,000−$133,000—$827,000$621,000—$0$0
Total shareholders' equity$4.1M$6.2M$12.8M$21.0M$31.1M$27.7M$7.7M$12.8M$8.0M$22.2M
Key figures
Total debt—$155,000$1.0M$2.0M$3.3M$9.4M$2.2M$29,000—$25.1M
Net cash (debt)—$4.1M$10.6M$18.6M$25.4M$16.3M$23.1M$21.8M—$25.4M
Working capital$4.3M$6.7M$11.4M$21.2M$30.3M$25.4M$22.7M$19.8M$11.5M$49.1M
Tangible book value$4.1M$6.2M$12.8M$21.0M$30.6M$26.9M$7.7M$12.8M$8.0M$22.2M
Book value per share$3.03$4.56$10.38$35.09$58.44—————
Shares outstanding1.4M1.4M1.2M599K532K—————
Current ratio3.093.614.176.037.025.024.987.494.2716.69
Quick ratio2.422.113.395.195.964.294.547.204.0416.33
Debt / equity—0.020.080.100.110.340.290.00—1.13
Equity / assets63.2%46.0%65.2%72.7%70.8%58.6%23.7%53.3%48.3%39.2%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 26, 2026); data from EODHD.

RKDA financial position

At the end of fiscal 2025 (December 31, 2025), Arcadia Biosciences had total assets of $6.5 million (down 51.6% from a year earlier), total liabilities of $2.4 million and shareholders' equity of $4.1 million. Its current ratio was 3.09. In the latest quarter (ended June 30, 2026) total assets were $5.9 million and equity $0.6 million.

Related: RKDA income statement, RKDA cash flow statement, RKDA key metrics. See the RKDA stock overview for the latest quote and news.

RKDA balance sheet FAQ

What are Arcadia Biosciences's total assets?

Arcadia Biosciences reported total assets of $6.5 million at the end of fiscal 2025 (December 31, 2025), compared with $13.5 million a year earlier.

How much cash does Arcadia Biosciences have?

Arcadia Biosciences held $4.6 million in cash and short-term investments at the end of fiscal 2025.

What is Arcadia Biosciences's book value?

Arcadia Biosciences's shareholders' equity (book value) was $4.1 million at the end of fiscal 2025, or $3.03 per share.

What is Arcadia Biosciences's current ratio?

Arcadia Biosciences had current assets of $6.4 million and current liabilities of $2.1 million, a current ratio of 3.09 (it can cover its short-term obligations).

How much goodwill does Arcadia Biosciences have?

Arcadia Biosciences carried $0.0 million of goodwill and intangible assets, 0.6% of total assets, at the end of fiscal 2025.

Packaged Foods: balance sheet